Skip to main content
. 2016 Feb 23;7(15):19824–19839. doi: 10.18632/oncotarget.7627

Table 2. Summary of Kaplan-Meier analysis of early-phase circulating miRNAs in predicting overall and disease-free survivals of HCC patients after liver transplantation.

miRNAs Kaplan-Meier analysis of Overall survival Kaplan-Meier analysis of Disease-free survival
Log-Rank value P value Log-Rank value P value
Let7C 0.606 0.436 0.646 0.422
miR-21 0.297 0.586 0.395 0.530
miR-23b 1.571 0.210 1.502 0.220
miR-27b 3.448 0.063 3.518 0.061
miR-122 6.505 0.011* 6.984 0.008**
miR-125b 1.757 0.185 2.021 0.155
miR-148a 4.530 0.033* 4.862 0.027*
miR-151p-5p 2.025 0.155 2.012 0.156
miR-192 5.301 0.021* 5.310 0.021*
miR-195 0.381 0.537 0.452 0.502
miR-199a-3p 0.008 0.927 0.063 0.802
miR-215 3.838 0.050* 4.440 0.035*
miR-1246 12.446 0.000*** 12.293 0.000***
miR-1290 6.201 0.013* 6.498 0.011*
*

p<0.05;

**

p<0.01;

***

P<0.001.